MedPath

ess invasive surfactant administration vs Intubation, surfactant and extubation in preterm neonates with respiratory distress syndrome

Phase 1
Not yet recruiting
Conditions
Health Condition 1: P220- Respiratory distress syndrome of newborn
Registration Number
CTRI/2021/04/032720
Lead Sponsor
Dr Ashu Jamwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Gestational age <= 34 weeks

2. Diagnosis of RDS based on clinical signs and confirmation by chest x ray findings and need for NIV support ( FiO2 >30 %; PEEP >6 H2O) to maintain saturation between 90% and 95% in the first 6 hours of life

Exclusion Criteria

1. Severe RDS been treated with endotracheal intubation

2. Major congenital malformation or complex CHD

3. Pulmonary haemorrhage

4. Cardiopulmonary failure

5. Congenital genetic metabolic disease

6. Gestational age less than 28 weeks

7. Transferred out of NICU with surgical treatment or other intervention

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath